Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AMPH
Amphastar Pharmaceuticals, Inc.
stock NASDAQ

At Close
May 16, 2025 3:59:30 PM EDT
24.86USD+2.220%(+0.54)510,675
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 12, 2025 9:27:50 AM EDT
23.78USD-2.220%(-0.54)0
After-hours
May 16, 2025 4:00:30 PM EDT
24.86USD0.000%(0.00)1,521
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 7, 2022
01:07PM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022   Benzinga
01:01PM EST  Piper Sandler Upgrades Amphastar Pharmaceuticals to Overweight, Raises Price Target to $28   Benzinga
Nov 9, 2021
05:49PM EST  Amphastar Pharmaceuticals Files For Mixed Shelf Of Up To $250M   Benzinga
11:17AM EST  Amphastar Pharmaceuticals: Q3 Earnings Insights   Benzinga
11:08AM EST  Amphastar Pharmaceuticals Q3 EPS $0.46 Beats $0.24 Estimate, Sales $112.20M Beat $103.24M Estimate   Benzinga
Nov 8, 2021
05:06AM EST  Earnings Scheduled For November 8, 2021   Benzinga
Aug 9, 2021
04:33PM EDT  Amphastar Pharmaceuticals Q2 Adj. EPS $0.21, Inline, Sales $101.70M Miss $101.78M Estimate   Benzinga
11:38AM EDT  Looking into Amphastar Pharmaceuticals's Return on Capital Employed   Benzinga
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Jun 15, 2021
04:05PM EDT  Amphastar Pharmaceuticals to Present at the Raymond James Human   GlobeNewswire Inc
May 27, 2021
06:00AM EDT  Amphastar Pharmaceuticals to Present at the Jefferies Virtual   GlobeNewswire Inc
May 7, 2021
04:06PM EDT  Amphastar Pharma Reports Buyback Of 26% Of Its Equity In Its ANP Subsidiary; ANP Will Spin Off Its Chinese Subsidiary, Nanjing Hanxin Pharma Technology Co.   Benzinga
04:05PM EDT  Amphastar Announces Buyback of 26% of the Equity in its ANP   GlobeNewswire Inc
May 6, 2021
05:45PM EDT  Recap: Amphastar Pharmaceuticals Q1 Earnings   Benzinga
04:51PM EDT  Amphastar Pharmaceuticals Q1 EPS $0.27 Beats $0.18 Estimate, Sales $103.02M Beat $97.26M Estimate   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 3, 2021
06:39AM EDT  The Food and Drug Administration approved the Abbreviated New Drug Application (ANDA) submitted by Amphastar Pharmaceuticals Inc. (AMPH) for its Morphine Sulfate injection, the company said in a release.   RTTNews
06:12AM EDT  Amphastar Pharma: FDA Approves ANDA For Morphine Sulfate Injection   RTTNews
06:10AM EDT  A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data   Benzinga
06:02AM EDT  Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection   Benzinga
06:00AM EDT  Amphastar Pharmaceuticals Receives FDA Approval for Morphine   GlobeNewswire Inc
Apr 29, 2021
06:00AM EDT  Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2021 ended March 31, 2021, after the market closes on Thursday, May 6th, 2021, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.   GlobeNewswire Inc
Apr 6, 2021
04:05PM EDT  Amphastar Pharmaceuticals to Present at the 20th Annual Needham   GlobeNewswire Inc
Mar 29, 2021
06:01AM EDT  Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection   Benzinga
Mar 17, 2021
08:07AM EDT  Wells Fargo Maintains Equal-Weight on Amphastar Pharmaceuticals, Lowers Price Target to $20   Benzinga
Mar 15, 2021
05:00PM EDT  Recap: Amphastar Pharmaceuticals Q4 Earnings   Benzinga
04:05PM EDT  Amphastar Pharmaceuticals Q4 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $95.90M Beat $88.94M Estimate   Benzinga
04:05PM EDT  Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months and full-year ended December 31, 2020.   GlobeNewswire Inc
04:53AM EDT  Earnings Scheduled For March 15, 2021   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Mar 8, 2021
05:39PM EST  Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2020 ended December 31, 2020, after the market closes on Monday, March 15th, 2021, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.   GlobeNewswire Inc
Feb 26, 2021
06:01AM EST  Amphastar Pharmaceuticals to Present at the Raymond James 2021   GlobeNewswire Inc
Jan 8, 2021
10:04AM EST  Benzinga's Top Upgrades, Downgrades For January 8, 2021   Benzinga
07:29AM EST  Wells Fargo Downgrades Amphastar Pharmaceuticals to Equal-Weight, Announces $21 Price Target   Benzinga
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
08:02AM EST  FDA Nod For First Generic Drug To Treat Severe Hypoglycemia   RTTNews
06:12AM EST  Amphastar Pharmaceuticals, Inc. (AMPH) said the FDA has approved its Abbreviated New Drug Application for Glucagon for Injection Emergency Kit, 1 mg. Glucagon is indicated for the treatment of severe hypoglycemia and is also used as a diagnostic aid. The company plans to launch Glucagon for Injection Emergency Kit, which it previously referred to as AMP-001, within two months.   RTTNews
06:11AM EST  A Peek Into The Markets: US Stock Futures Rise After Hitting Record Highs In Previous Session   Benzinga
06:06AM EST  Amphastar Says FDA Approved Its ANDA For Glucagon For Injection Emergency Kit, 1 Mg   RTTNews
06:02AM EST  Amphastar Announces FDA Approval Of Abbreviated New Drug Application For Glucagon For Injection Kit, 1mg   Benzinga
06:00AM EST  Amphastar Announces Approval for Glucagon for Injection Kit, 1mg   GlobeNewswire Inc
Dec 28, 2020
05:47PM EST  FDA Granted Approval of First Generic of Drug Used to Treat Severe Hypoglycemia for Injection to Amphastar Pharmaceuticals   Benzinga
Nov 6, 2020
07:52AM EST  Recap: Amphastar Pharmaceuticals Q3 Earnings   Benzinga
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
06:53AM EST  Amphastar Pharmaceuticals Q3 Adj. EPS $0.15 Beats $0.14 Estimate, Net Sales $83.40M Miss $91.26M Estimate   Benzinga
06:50AM EST  Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2020.   GlobeNewswire Inc
03:33AM EST  Earnings Scheduled For November 6, 2020   Benzinga
Nov 5, 2020
10:06AM EST  Earnings Outlook For Amphastar Pharmaceuticals   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 6, 2020
09:49AM EDT  Amphastar Pharmaceuticals shares are trading higher after the company announced it received FDA approval for its Atropine Sulfate Injection.   Benzinga
06:06AM EDT  Amphastar Pharma: FDA Approves ANDA For Atropine Sulfate Injection 0.1mg/mL In 10 ML Luer-Jet Prefilled Syringe System   RTTNews
06:01AM EDT  Amphastar Pharmaceuticals Receives FDA Approval For Atropine Sulfate Injection   Benzinga
06:00AM EDT  Amphastar Pharmaceuticals Receives FDA Approval for Atropine   GlobeNewswire Inc
Oct 5, 2020
10:44AM EDT  Price Over Earnings Overview: Amphastar Pharmaceuticals   Benzinga
10:38AM EDT  Why Amphastar's Stock Is Trading Higher Today   Benzinga
09:09AM EDT  Northland Capital Markets Upgrades Amphastar Pharmaceuticals to Outperform   Benzinga
Sep 3, 2020
04:05PM EDT  Amphastar Pharmaceuticals to Present at the Wells Fargo 2020   GlobeNewswire Inc
Aug 6, 2020
05:08PM EDT  Amphastar Pharmaceuticals Q2 EPS $0.16 Beats $0.14 Estimate, Sales $85.81M Miss $86.62M Estimate   Benzinga
Aug 5, 2020
12:18PM EDT  Amphastar Pharmaceuticals's Earnings: A Preview   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC